
Kenvue, which has been beneath elevated scrutiny not too long ago after the Trump administration alleged a hyperlink between Tylenol and autism, is being acquired by Kimberly-Clark in a multibillion-dollar deal.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
			






:max_bytes(150000):strip_icc()/Health-GettyImages-2193878302-904ec3a8db834ef6bdd31f8ea0793085.png?ssl=1)

